Biomarker name Expression pattern Clinical Application PMID Link
TRPV2 expression prognosis(recurrence) 34936030 View
circulating tumor DNA (ctDNA) ctDNA detect prognosis(tumor recurrence) 33536036 View
CEP17 HER-2:CEP17 ratio > 4 < or = 5 prognosis(unfavorable) 12866577 View
KAI1 down-regulated prognosis(unfavorable) 12684410 View
Ribosomal DNA methylation low-level prognosis(unfavorable) 12115383 View
TERT expression diagnosis 11078809 View
PTEN Altered expression diagnosis(earliest endometrial precancers) 10841828 View
p16INK4aa Loss of nuclear expression prognosis(unfavorable) 10656444 View
HER-2/neu amplification prognosis(unfavorable) 10202671 View
PTEN mutation prognosis(favorable) 9865913 View
CK-20 positive expression diagnosis 9790796 View
p53 abnormalities prognosis(unfavorable) 9422988 View
GHSR increased methylation levels diagnosis(non-invasive detection) 33143739 View
p21 expression prognosis(favorable) 9422988 View
growth fraction growth fraction rate prognosis 9340973 View
DNA aneuploidy DNA aneuploidy diagnosis(biological markers for assessing progression to endometrial carcinoma) 9167896 View
SPF high(> 9%) diagnosis(assessing progression to endometrial carcinoma) 9167896 View
S-phase fraction (SPF) prognosis(unfavorable) 8909315 View
apoptotic index prognosis(unfavorable) 8575739 View
AgNOR expression diagnosis 8112955 View
DNA ploidy prognosis(unfavorable) 7909491 View
CK-20 expression diagnosis 10831349 View
DNA ploidy DNA ploidy diagnosis 22824999 View
SST increased methylation levels diagnosis(non-invasive detection) 33143739 View
DNA ploidy DNA ploidy diagnosis 22824999 View
Circulating cell free DNA detected diagnosis 35449078 View
cell free DNA (cfDNA) cut-off=712.3 diagnosis 35449078 View
NHP2 downgulated prognosis(favorable) 35054812 View
CHADL upregulate diagnosis 36052469 View
two miRNAs (409 and 200c) and 8 CpG sites (4 CpGs at SLC22A18, 3 at HYAL2, and 1 at FUT7) diagnosis 35284957 View
zinc finger and SCAN domain containing 12 (ZSCAN12) and/or oxytocin (OXT) hypermethylation diagnosis 35323926 View
TP53 mutations prognosis 36251972 View
Pirh2 upregulated prognosis 36251972 View
EPM2AIP1 upregulated diagnosis 34772843 View
ZIC1 increased methylation levels diagnosis(non-invasive detection) 33143739 View
L1CAM upregulated treatment 35429348 View
KRT15 upregulated prognosis 35866777 View
MutS homolog 2 Increased MSH2 expression and reduced MSH2 methylation prognosis 36208091 View
HER2 upregulated prognosis 35611517 View
FTO FTO demethylates m6A modifications treatment(theranostic target) 33103587 View
mismatch repair status mismatch repair deficiency treatment(predictive biomarker for hormone therapy respons) 33039397 View
VDAC1 expression(≥ median value) prognosis(unfavorable) 32829673 View
VDAC2 expression(≥ median value) prognosis(unfavorable) 32829673 View
MMR status dMMR prognosis(unfavorable) 30561762 View
CK19 cutoff value = 4,500 copies/µL diagnosis(LN metastasis) 30428472 View
TRPV2 expression diagnosis 34936030 View
Autotaxin expression treatment(theranostic target) 30374843 View
UCHL1 high expression prognosis(unfavorable) 29489474 View
DNA integrity index diagnosis 29382392 View
mPRβ prognosis(favorable) 29353001 View
mPRγ prognosis(favorable) 29353001 View
Asparaginase-like protein 1 loss expression prognosis(unfavorable) 29096882 View
IRAK1 overexpression treatment(theranostic target) 28980703 View
SerpinE2 expression prognosis(unfavorable) 28453461 View
STAR down-regulated prognosis 28232277 View
AKR1B10 down-regulated prognosis 28232277 View
TET1 loss of expression prognosis(unfavorable) 34731191 View
HSD17B1 high mRNA level prognosis(unfavorable) 27923582 View
HSD17B1 high HSD17B1 and HSD17B2 prognosis(unfavorable) 27923582 View
HSD17B2 high HSD17B1 and HSD17B2 prognosis(unfavorable) 27923582 View
MIF overexpresses diagnosis 26985869 View
c-erbB-2 overexpresses diagnosis 26985869 View
ZNF154 CpG hypermethylation diagnosis(identifying solid tumor DNA) 26857064 View
POLE exonuclease domain mutations (EDM) mutations prognosis(favorable) 26763250 View
CXCR4 expression treatment(theranostic target) 26678890 View
CXCR7 expression treatment(theranostic target) 26678890 View
CCNE1 amplification treatment(theranostic target) 26647729 View
TET1 loss of expression diagnosis 34731191 View
ATAD2 overexpression(index 3-9) prognosis(unfavorable) 26308378 View
CDKN2A prognosis 26283007 View
CDKN2A differentially expressed diagnosis(MT-EC(containing endometrioid and serous differentiation)) 26132201 View
H19 differentially expressed diagnosis(MT-EC(containing endometrioid and serous differentiation)) 26132201 View
HOMER2 differentially expressed diagnosis(MT-EC(containing endometrioid and serous differentiation)) 26132201 View
TNNT1 differentially expressed diagnosis(MT-EC(containing endometrioid and serous differentiation)) 26132201 View
ZEB1 expression diagnosis(predict the lymph node metastasis) 25544793 View
Rictor expression prognosis(unfavorable) 24966915 View
Rictor expression prognosis(unfavorable) 24966915 View
CYP1A1 overexpression treatment(chemotherapeutic targets) 24957043 View
CTNNB1 CTNNB1 exon 3 mutation prognosis(unfavorable) 34420090 View
CYP1B1 overexpression treatment(chemotherapeutic targets) 24957043 View
FOXA1 low expression prognosis(unfavorable) 24849812 View
POLE exonuclease domain mutations prognosis(favorable) 24844595 View
S100A4 cytoplasmic expression prognosis(unfavorable) 24756855 View
CGRRF1 treatment(metformin respons) 24680596 View
RASSF1 methylation prognosis(prognostic factor of endometrial carcinogenesis) 24464006 View
RASSF1 methylation prognosis(prognostic factor of endometrial carcinogenesis) 24464006 View
CDH1 expression diagnosis 24455846 View
ITGB1 expression diagnosis 24455846 View
SPAG9 expression diagnosis 22146769 View
CTNNB1 CTNNB1 exon 3 mutation diagnosis 34420090 View
endoglin expression prognosis(not significantly altered ) 22116456 View
survivin allele C treatment(therapeutic implications) 21897272 View
p21 low p21(<1%) , high survivin expression(>158) and high microsatellite instability prognosis(unfavorable) 21552210 View
survivin low p21(<1%) , high survivin expression(>158) and high microsatellite instability prognosis(unfavorable) 21552210 View
Microsatellite instability low p21(<1%) , high survivin expression(>158) and high microsatellite instability prognosis(unfavorable) 21552210 View
HE4 expression prognosis(unfavorable) 21468050 View
MSI-H status High frequency prognosis(unfavorable) 21079294 View
CDH1 CDH1 promoter hypermethylation prognosis 20874004 View
CDH1 CDH1 promoter hypermethylation treatment(therapeutic targe) 20874004 View
YT521 exon 6-skipping mRNA splicing isoform of YT521 (high level ) prognosis(unfavorable) 20686370 View
rs1137101 heterozygous genotype AG of SNP LEP-R c.668A>G prognosis(protective factor in the development of endometrial cancer) 34399708 View
MSI BAT-25, BAT-26, NR21, NR24, and NR27 prognosis(unfavorable) 20005452 View
DNA ploidy aneuploid prognosis(unfavorable) 19800606 View
TFF3 expression diagnosis 18682706 View
BMI-1 Loss expression prognosis(unfavorable) 18475299 View
beta-catenin exon 3 diagnosis 18376386 View
Prostate-specific membrane antigen loss expression prognosis(unfavorable) 18349274 View
Microsatellite instability MSI-high prognosis(unfavorable) 17527071 View
ephrinB2 Overexpression prognosis(unfavorable) 17108150 View
EphB4 Overexpression prognosis(unfavorable) 17108150 View
PRB loss or absence prognosis(risk factor in disease-free survival of the patients) 16999816 View
TMEFF2 highly expression(>5) prognosis(unfavorable) 34339705 View
PRA loss or absence prognosis(risk factor in disease-free survival of the patients) 16999816 View
TADG-14 TADG-14/KLK8 expression diagnosis 16888409 View
KLK8 TADG-14/KLK8 expression diagnosis 16888409 View
ERRalpha expression;amplification prognosis 16681769 View
ERRgamma expression;amplification prognosis 16681769 View
Haymaker positive expression diagnosis 16495475 View
EIG121 expression prognosis(hyperestrogenic state and estrogen-related) 16322283 View
PTEN lack expression prognosis(unfavorable) 15948123 View
Human kallikrein 6 (hK6) expression prognosis(unfavorable) 15867230 View
Human kallikrein 6 (hK6) expression prognosis(unfavorable) 15867230 View
SMOC-2 highly expression(>5) prognosis(unfavorable) 34339705 View
Human kallikrein 6 (hK6) expression prognosis(unfavorable) 15867230 View
Human kallikrein 6 (hK6) expression prognosis(unfavorable) 15867230 View
Human kallikrein 6 (hK6) expression treatment(response to therapy) 15867230 View
DNA ploidy prognosis 15755004 View
PR Low Expression and carrying the PROGINS allele prognosis(unfavorable) 15726651 View
Smad7 Overexpression prognosis(unfavorable) 15661223 View
Smad7 Overexpression treatment(potential target to restore TGF-beta responsiveness) 15661223 View
DNA ploidy DNA ploidy prognosis(unfavorable) 15068320 View
DNA ploidy diploid versus nondiploid; RR 5.1 prognosis 14981988 View
PTEN Loss expression diagnosis 12948417 View

Institutes for Systems Genetics, West China Hospital
     Copyright @ 2023 ISG. All Rights Reserved.